Nobody needs to be concerned, just release of 60c IPO shares. Unlikely to be sold on-market and hardly at current price anyway.
Last hours for retail to participate. Time will tell whether we should have waited for lower combined heads and oppies (tradable 28 November) or if that was the best deal.
PH and Co got a lot of criticism at the 3 AGMs which was mostly related to the sp. Not one substantial claim regarding company activities apart of just phrases such as " Wasting our money / Snout in trough / Screwing us over ....." which those people couldn't even prove.
IMU just flew in its CF33 inventors to AUS. These guys know the bio space like no other and they confirmed that the 3 Hopper companies drive trials with an extraordinary speed, 4-5 years compared to 20-25 years not long ago, due to cutting edge safety and efficacy data in pre-clinical and clinical trials which the market has ignored so far.
It is a LT play and the sp currently isn't related to the company progress, macros and fear dominating many retail holders decisions.
Of course I will be called Hopper's Pet / Buddy just because I trust the management teams of the companies I have invested in. That's the way it is stated in all good investment books but these days obviously it is wrong.
GLTA
RAD Price at posting:
12.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)